Holen Sie sich die Stockscreener-App
0.349
3.01%
0.0102
Handel nachbörslich:
.39
0.041
+11.75%
Schlusskurs vom Vortag:
$0.3388
Offen:
$0.3477
24-Stunden-Volumen:
454.23K
Relative Volume:
0.14
Marktkapitalisierung:
$20.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.26M
KGV:
-0.2954
EPS:
-1.1814
Netto-Cashflow:
$-13.50M
1W Leistung:
-4.54%
1M Leistung:
-11.65%
6M Leistung:
+27.98%
1J Leistung:
-85.52%
1-Tages-Spanne:
$0.3401
$0.355
1-Wochen-Bereich:
$0.3366
$0.3793
52-Wochen-Spanne:
$0.1853
$2.5322
Intensity Therapeutics Inc Stock (INTS) Company Profile
Firmenname
Intensity Therapeutics Inc
Sektor
Branche
Telefon
203-221-7381
Adresse
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Compare INTS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.349 | 20.35M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.92 | 116.41B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.51 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
811.45 | 50.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.76B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
353.92 | 38.40B | 4.98B | 69.60M | 525.67M | 0.5198 |
Intensity Therapeutics Inc Aktie (INTS) Neueste Nachrichten
Recap Report: Is Smithfield Foods Inc showing insider buyingGap Up & Reliable Volume Spike Alerts - baoquankhu1.vn
Volume Summary: Is Faraday Future Intelligent Electric Inc being accumulated by smart moneyLayoff News & Technical Buy Zone Confirmations - baoquankhu1.vn
Chart Watch: Is Intensity Therapeutics Inc stock a top performer YTD2025 Geopolitical Influence & Weekly High Return Stock Opportunities - baoquankhu1.vn
Stop Loss: Can Intensity Therapeutics Inc. ride the EV waveAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Should I hold or sell Intensity Therapeutics Inc. stock in 20252025 Short Interest & Stepwise Entry and Exit Trade Signals - bollywoodhelpline.com
Aug Mood: How do insiders feel about OptiNose Inc2025 Performance Recap & Low Drawdown Momentum Ideas - baoquankhu1.vn
Intensity therapeutics outlines 2026 priorities after clinical validation By Investing.com - Investing.com India
Layoff Watch: Is Intensity Therapeutics Inc stock a top pick in earnings season2025 Geopolitical Influence & High Conviction Trade Alerts - Bộ Nội Vụ
Intensity therapeutics outlines 2026 priorities after clinical validation - Investing.com
Intensity Therapeutics highlights 2025 milestones and outlines 2026 strategic priorities - marketscreener.com
Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities - PR Newswire
Is Intensity Therapeutics Inc stock influenced by commodity pricesJuly 2025 Recap & Real-Time Volume Spike Alerts - baoquankhu1.vn
What insider trading reveals about Intensity Therapeutics Inc. stockEntry Point & Growth Oriented Trade Recommendations - Улправда
Why Intensity Therapeutics Inc. stock is rated strong buyLightweight Speed Options & trail grip notes for mixed terrain - Улправда
Can Intensity Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Analyst Calls & Precise Entry and Exit Recommendations - Улправда
Can Intensity Therapeutics Inc. stock attract ESG capital inflowsShort Setup & Technical Pattern Alert System - Улправда
Why Intensity Therapeutics Inc. stock appeals to analysts2026 world cup usa national team group stage playmakers set piece tactics expert forecast analysis - Улправда
Intratumoral Cancer Therapies Market Expected to Gain Momentum Through 2034, According to DelveInsight - openPR.com
Can VMS Industries Limited Achieve Earnings Growth in a SlowdownPrice Support Zones & Free Tap Rapid Wealth - earlytimes.in
Pullback Watch: Why Intensity Therapeutics Inc. stock appeals to analysts2025 Geopolitical Influence & Safe Entry Point Alerts - Bộ Nội Vụ
Intensity Therapeutics plunges on $2.35M public offering - MSN
Intensity Therapeutics receives 180-day Nasdaq extension to regain compliance - MSN
Intensity Therapeutics (INTS) Stock Price, Quote, News & History - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Why Intensity Therapeutics Inc. stock is a must watch in 2025July 2025 Analyst Calls & Weekly High Conviction Ideas - Улправда
Can Intensity Therapeutics Inc. stock double in next 5 years2025 Fundamental Recap & Weekly Breakout Watchlists - Улправда
CEO Change: Can Intensity Therapeutics Inc. stock attract ESG capital inflows2025 Risk Factors & Precise Buy Zone Identification - moha.gov.vn
How Intensity Therapeutics Inc. stock performs in high volatility marketsJuly 2025 Big Picture & Real-Time Stock Entry Alerts - Улправда
Portfolio Shifts: Will Intensity Therapeutics Inc. stock split attract more investorsPortfolio Return Report & Real-Time Buy Signal Notifications - Улправда
Will Intensity Therapeutics Inc. stock split attract more investorsJuly 2025 News Drivers & AI Based Buy and Sell Signals - Улправда
Growth Review: What insider trading reveals about Intensity Therapeutics Inc. stockJuly 2025 Sector Moves & AI Based Trade Execution Alerts - DonanımHaber
Published on: 2025-12-19 09:02:42 - Улправда
Fundamentals Check: Can Intensity Therapeutics Inc. stock double in next 5 yearsWeekly Gains Report & Growth Focused Entry Reports - Улправда
Can Intensity Therapeutics Inc. stock resist sector downturns2025 Earnings Impact & Fast Gain Stock Tips - Улправда
Is Intensity Therapeutics Inc. stock supported by innovation pipelineDip Buying & Daily Volume Surge Trade Alerts - Улправда
Market Review: Why Intensity Therapeutics Inc. stock is a must watch in 2025IPO Watch & Verified Technical Signals - Улправда
MSN Money - MSN
Intensity Therapeutics to present two posters ay SABCS - MSN
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy - sharewise.com
All you need to know about Intensity Therapeutics Inc. (INTS) rating upgrade to buy - MSN
Immuron (IMRN) struggles after announcing trial results - MSN
Value Recap: Is Intensity Therapeutics Inc stock positioned for digital transformationJuly 2025 Snapshot & Technical Confirmation Trade Alerts - moha.gov.vn
Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium - PR Newswire
What drives Intensity Therapeutics Inc stock priceTechnology Stock Trends & Explosive Profit Potential - earlytimes.in
Intensity Therapeutics reports Q3 EPS (6c) vs. (25c) last year - MSN
Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen - PR Newswire
You might want to take a look at Intensity Therapeutics Inc (INTS) now - setenews.com
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement - marketscreener.com
Intensity Therapeutics granted 180-day extension to regain Nasdaq compliance - MSN
INTS Stock Price and Chart — NASDAQ:INTS - TradingView
Update Report: How Intensity Therapeutics Inc stock benefits from global expansionPortfolio Gains Summary & AI Based Trade Execution Alerts - moha.gov.vn
Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
1.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):